Is there such a thing as a healthy movie theater snack? 7 treats I reach for as a dietitian.
Call it the magic of the movies or a cultural rite; something about that darkened room screams, 'Treat yourself!' But as a dietitian, I'm here to ask the question nobody really wants answered after their third handful of Reese's Pieces: Is there such a thing as a healthy movie theater snack?
Before you hit me with the theatrical boos, hear me out! This isn't about shaming your Milk Duds or butter-soaked popcorn cravings. But the reality is, some movie theater snacks are better for you than others. So, if you're focused on making smarter choices without ruining the fun, there are options that strike a balance.
One key factor I look for in a snack is whether it contains fiber, protein or healthy fats (bonus points if it has all three). Why? Because these nutrients help you feel fuller for longer, keep blood sugar levels stable and provide sustained energy, which is an essential combo, especially for a long movie. Bonus points if a snack is low in added sugar or salt and free of artificial colors or flavors, though admittedly, finding that unicorn at the theater can be a challenge!
Among the sea of movie theater snacks out there, here are some of my dietitian-approved, top picks for movie theater noshing.
Popcorn is a classic movie snack, and it's actually a whole grain! A small or kid-size portion (without drenching it in butter or overly salty toppings) can serve as a crunchy, satisfying option. Plain popcorn is rich in fiber, which is beneficial for digestion, and a small serving usually clocks in around 120-250 calories. Plus, it's light enough to snack on without feeling sluggish. Just skip the added butter or powdered cheese sprinkles.
Yes, Raisinets can be a healthy snack! Beneath that chocolate coating are real raisins, which provide natural sugars for energy along with small amounts of fiber and potassium. A serving of Raisinets isn't exactly a health food, but it's a sweet treat that's better balanced thanks to the raisins' nutrient content. At around 190 calories for a small box, this snack is perfect for satisfying a sweet tooth while still providing a bit of fruit. And the chocolate provides some antioxidants, which is good for you too.
Soft pretzel bites can be a fun snack to share, and pairing them with mustard instead of cheese sauce is a simple way to reduce excess saturated fat and calories. Mustard is naturally low in calories and adds a tangy twist to your snack. Pretzels are a good source of carbohydrates, making them a great energy booster to keep you focused on the action onscreen. A serving of pretzel bites typically contains 200-400 calories, so sharing them with a friend can also be a great option.
Peanut M&M's might seem like an indulgent choice, and they are. But they come with a surprising perk: plant-based protein. Thanks to the peanuts inside, this snack offers a small dose of protein (about 5 grams per serving) to help promote satiety and balance out the sweetness. Additionally, the nuts provide healthy fats that help prevent a sugar spike and crash. A standard serving of Peanut M&M's is about 240 calories, making it a better pick than snacks that are pure sugar. Just be mindful of the serving size.
Skip the oversize soda and opt for a cup of coffee instead. It is naturally calorie-free (unless you add cream and sugar), and it can help keep you alert during a late-night screening. Coffee contains antioxidants and provides a natural source of caffeine for a quick energy boost without the sugar overload that comes with sodas or energy drinks. Pro tip: Many theaters offer unsweetened iced tea during the summer months, so look out for this refreshing and low-calorie option if you need something cool. Tea has antioxidants too!
Some theaters, like AMC, are stepping up their snack game by offering high-protein options like Country Archer Grass-Fed Beef Jerky. A serving of this jerky is typically around 70–100 calories and provides about 9 grams of protein per ounce. High in protein and low in sugar, this treat is a satiating choice for long movies and adds a savory, chewy texture to your snack lineup.
Many theaters offer a kids combo, which might secretly be the perfect option for the 'kids at heart' too. Most theaters are happy to sell it to adults, so don't hesitate to ask. The combo usually includes a small popcorn, a mini drink and a treat like a fruit snack or candy. For those who can't imagine a theater visit without an Icee, the kids combo is a great way to indulge without going overboard. A smaller portion means you can still get that nostalgic taste without committing to a supersize sugar rush. It's a manageable, fun-size option that keeps your snack cravings in balance while adding a bit of whimsy to your movie experience.
It's important to remember that enjoying snacks at the theater doesn't have to feel like a guilty pleasure. This list isn't about strict rules — it's about finding options that satisfy your cravings while also helping you feel good. Choosing smaller portions, sharing snacks or pairing something indulgent (like chocolate) with something a bit more nutritious (like jerky) can help you strike a satisfying balance.
Ultimately, a trip to the movies is about fun and entertainment, so don't overthink your snack choices. A little mindfulness goes a long way, and armed with these options, you can enjoy snacking without hesitation. After all, good food and great movies go hand in hand!

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
DEA Cannabis Poisoned, Zero Oversight-Massachusetts Lab Scandal: A Case Study in DEA's Regulatory Collapse
Poisoned Cannabis, Zero DEA Oversight The DEA's mission statement is a sham under Thomas Prevoznik's watch. Americans are being poisoned by untested state cannabis operators while terminal patients are denied potential cures. WASHINGTON, D.C. / / July 6, 2025 / The Drug Enforcement Administration (DEA) exists to "prevent, detect, and investigate the diversion of controlled substances while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs". Yet under the leadership of Deputy Administrator Thomas Prevoznik, the DEA's Diversion Control Division has catastrophically failed this mission. Instead of protecting public health, the agency has allowed contaminated cannabis to flood state markets-poisoning consumers-while simultaneously blocking federally compliant pharmaceutical research that could save lives. This is not just bureaucratic incompetence; it is systemic negligence bordering on malpractice. 1. DEA's Mission Failure: Poisoned Cannabis, Zero Oversight The Massachusetts Scandal: A Case Study in Regulatory Collapse In Massachusetts, Assured Testing Laboratories-a facility responsible for testing 25% of the state's cannabis-was caught falsifying safety reports, concealing contamination, and approving products that should have failed for yeast, mold, and microbial toxins. Thousands of tainted products reached consumers, yet the DEA: Took no enforcement action Issued no national recall Failed to intervene despite its mandate to prevent diversion and ensure safety. This is not an isolated incident. Across the U.S., unregulated cannabis markets operate like the "Wild West"-with no federal quality control, no uniform safety standards, and no accountability. The DEA, under Prevoznik, has abdicated its duty, leaving Americans exposed to dangerous products while offering no recourse. 2. Blocking Medical Breakthroughs: The DEA's War on Science While turning a blind eye to contaminated street cannabis, the DEA has actively obstructed federally approved pharmaceutical research. MMJ BioPharma, a company developing cannabis-based treatments for Huntington's Disease and Multiple Sclerosis, has faced seven years of bureaucratic sabotage despite: Holding FDA Investigational New Drug (IND) approvals Securing Orphan Drug Designation for Huntington's therapy Passing DEA security inspections. Yet, Prevoznik's division refuses to grant MMJ a bulk manufacturing license, citing a retroactive "Bona Fide Supply Agreement" (BFSA) requirement that creates an impossible Catch-22: No supplier will sign a contract without DEA approval. DEA won't approve without a signed contract. This obstruction is not just regulatory failure-it's deliberate stonewalling. As MMJ's legal filings reveal, DEA Administrative Law Judges (ALJs) operate in a structurally biased system, where registrants win only 20-25% of cases, and the DEA overturns nearly all pro-registrant rulings. 3. The Human Cost: Patients Suffer While Illicit Markets Thrive The DEA's hypocrisy is staggering: Patients with epilepsy, cancer, and neurological disorders are denied access to standardized, pharmaceutical-grade cannabis112. Meanwhile, unregulated THC products-laced with pesticides, mold, and heavy metals-flood the market, making consumers sick 15. Prevoznik's DEA has created the worst of both worlds:No protection for consumers from tainted pathway for research into life-saving medicines. 4. Time for Accountability: Fire Prevoznik, Overhaul the DEA The solution is clear: Remove Thomas Prevoznik for gross negligence and regulatory malpractice. Transfer cannabis oversight to the FDA/NIH, where science-not stigma-guides policy. Investigate DEA's Diversion Control Division for systemic bias and corruption. As MMJ BioPharma CEO Duane Boise stated: "The DEA's Diversion Control Division, under Prevoznik's leadership, has failed to protect the public, failed to uphold science, and failed to meet even the most basic standards of competence." Fire Thomas Prevoznik: A Call to Action The DEA's mission statement is a sham under Prevoznik's watch. Americans are being poisoned by untested cannabis while terminal patients are denied potential cures. Congress must intervene, the courts must act, and the public must demand accountability. Enough is enough. It's time to end the DEA's obstructionism and put public health over bureaucracy. MMJ is Represented by Attorney Megan Sheahan and Associates CONTACT:Madison Hiseymedia@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wall Street Journal
39 minutes ago
- Wall Street Journal
The MAHA Movement Loves Psychedelics. Should Wall Street?
Just about everyone in the 'Make America Healthy Again' (MAHA) movement seems bullish on psychedelics. Robert F. Kennedy Jr. has spoken favorably about the treatments, and President Trump's surgeon general pick, Casey Means, has described psilocybin therapy (known as magic mushroom) as 'one of the most meaningful experiences of life.' That kind of political enthusiasm might suggest a ripe buying opportunity for investors. But Wall Street and pharmaceutical companies have largely stayed on the sidelines. Questions remain. Chief among them is how to commercially scale treatments that leave patients high for several hours.
Yahoo
an hour ago
- Yahoo
Air Pollution 'Strongly Associated' With DNA Mutations Tied to Lung Cancer
Lung cancer cases are on the rise in non-smokers around the world, and air pollution could be an insidious, contributing factor. A genome study has now found that outdoor smog and soot are strongly associated with DNA mutations related to lung cancer – including known drivers seen in smokers, and new ones unique to non-smokers. The more pollution someone was exposed to, the more mutations scientists found in their lung tumors. The findings don't mean that air pollution is directly causing lung cancer, but they do contribute to evidence suggesting that possibility. Related: "We're seeing this problematic trend that never-smokers are increasingly getting lung cancer, but we haven't understood why," explains biomolecular scientist Ludmil Alexandrov from the University of California San Diego (UCSD). "Our research shows that air pollution is strongly associated with the same types of DNA mutations we typically associate with smoking." The extensive international analysis examined the cancer genomes of 871 individuals from four continents, all of whom had lung cancer despite never having smoked and who had not yet received cancer treatment. Those who lived in regions with high levels of air pollution were significantly more likely to have TP53 mutations, EGFR mutations, and shorter telomeres. Abnormal TP53 and EGFR genes are hallmarks of lung cancers, especially those driven by the SBS4 DNA mutation, and shorter telomeres are linked to accelerated aging. In the current study, non-smokers who lived in areas with higher air pollution were nearly four times more likely to exhibit SBS4 signatures as those who lived in regions with cleaner air. By contrast, exposure to secondhand smoke, which is a known cancer risk, showed only a slight increase in genetic mutations. "If there is a mutagenic effect of secondhand smoke, it may be too weak for our current tools to detect," says geneticist Tongwu Zhang from the US National Cancer Institute (NCI). Not so for air pollution or tobacco smoking: both were strongly linked to DNA mutations. Today in the United States, people who have never smoked or who have smoked fewer than 100 cigarettes in their lives make up about 10 to 20 percent of lung cancer cases. Scientists have long suspected that air pollution could be a contributing factor, but exactly how fine particulate matter in the air compares to tobacco smoking or secondhand smoke exposure remains unclear. Some studies suggest that breathing polluted air is on par with smoking a pack a day, and yet these conclusions are mostly based on observational analyses. The current study digs further by looking at some of the molecular mechanisms that may be at play. It compared the lung cancer genomes of the 871 non-smokers with tumors from 345 smokers, to find similarities and differences. The majority of non-smokers with lung cancer had adenocarcinomas (the most common type of lung cancer), and nearly 5 percent of those tumors showed the SBS4 mutational signature. In addition, 28 percent of non-smokers showed a new signature called SBS40a, which wasn't found in tobacco smokers. Strangely, the cause of this particular mutational driver was unknown, but doesn't seem to be environmental in nature. "We see it in a majority of cases in this study, but we don't yet know what's driving it," says Alexandrov. "This is something entirely different, and it opens up a whole new area of investigation." The current research relied only on regional air pollution levels, which means it can't say how much any one individual was directly exposed to fine particulate matter in the air. Participants who said they had never smoked may have also smoked more than reported. These limitations notwithstanding, the overall findings align with other evidence indicating that soot or smog may trigger tumor growth in a similar way to cigarette chemicals. "This is an urgent and growing global problem that we are working to understand regarding never-smokers," says epidemiologist Maria Teresa Landi from the NCI. The team now hopes to expand their study to include cancer genomes from a more diverse, global cohort. The study was published in Nature. FDA Issues Warning Over Dangerous 'Gas Station Heroin' Substance Mysterious Leprosy Pathogen Has Lurked in The Americas For 4,000 Years Massive Review Finds No 'Safe' Level of Processed Meat Consumption